Home › Funds › RA CAPITAL MANAGEMENT, L.P. › GERN
RA CAPITAL MANAGEMENT, L.P. position in GERN
GERON CORP · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 42,754,145 shares of GERN (GERON CORP) in its Q3 2026 13F filing — a position valued at US$52.6M, representing 0.54% of its reported portfolio and ranking #33 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed GERN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s GERN position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in GERN in Q3 2023 at 46,202,425 shares (US$97.9M). The position peaked in Q2 2024 at 46,202,425 shares, worth US$195.9M. Across 13 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 42,754,145 shares valued at US$52.6M. Notable position changes include a 30% trim in Q3 2024 (shares fell 22% over the following quarter), a 101% increase in Q1 2025 (shares fell 11% over the following quarter), a 33% trim in Q2 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 46.20M | $97.95M | New |
| Q4 2023 | 46.20M | $97.49M | Hold |
| Q1 2024 | 46.20M | $152.47M | Hold |
| Q2 2024 | 46.20M | $195.90M | Hold |
| Q3 2024 | 32.29M | $146.58M | Reduce |
| Q4 2024 | 30.01M | $106.23M | Reduce |
| Q1 2025 | 60.38M | $96.00M | Add |
| Q2 2025 | 60.38M | $85.13M | Hold |
| Q3 2025 | 60.38M | $82.72M | Hold |
| Q4 2025 | 63.77M | $84.18M | Add |
| Q1 2026 | 63.77M | $95.02M | Hold |
| Q2 2026 | 42.81M | $54.80M | Reduce |
| Q3 2026 | 42.75M | $52.59M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GERN and 13F data
GERN (GERON CORP) is a Health Care company. 17 other funds we track also report a position in GERN — the largest reported positions include Soleus Capital Management, L.P. (US$57.5M), Eversept Partners, LP (US$22.8M), Nantahala Capital Management, LLC (US$17.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GERN
- Soleus Capital Management, L.P. 46.77M sh · $57.53M · Q3 2026
- Eversept Partners, LP 18.53M sh · $22.79M · Q3 2026
- Nantahala Capital Management, LLC 13.87M sh · $17.06M · Q3 2026
- Kynam Capital Management, LP 6.84M sh · $8.41M · Q3 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held GERN?
RA CAPITAL MANAGEMENT, L.P. has disclosed GERN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in GERN?
As of Q3 2026, RA CAPITAL MANAGEMENT, L.P. holds 42.75M shares of GERN (GERON CORP), valued at $52.59M, representing 0.54% of its reported portfolio and ranking #33.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling GERN?
In the latest 13F filing (Q3 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in GERN. The position peaked in Q2 2024 at 46.20M shares.
Which other funds hold GERN?
Other major institutional holders of GERN include Soleus Capital Management, L.P., Eversept Partners, LP, Nantahala Capital Management, LLC, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.